BEIJING SUCCEEDER TECHNOLOGY INC.

Chikalata chachinayi chofunikira chogwirizana, chomwe chimatsogozedwa ndi Komiti Yoona za Kutsekeka kwa Magazi ndi Kutaya Madzi m'thupi ya Chinese Association of Research Hospitals, chatulutsidwa.

"Mgwirizano wa Akatswiri pa Kuyang'anira Mankhwala Ofanana ndi Heparin" unapangidwa pamodzi ndi Komiti ya Thrombosis and Hemostasis ya Chinese Association of Research Hospitals ndi Laboratory Science Branch ya Chinese Geriatrics Society. Chikalatachi, cholembedwa pamodzi ndi akatswiri ochokera ku China konse, chinatenga zaka ziwiri kuti chipangidwe, pambuyo pa zokambirana zambiri ndi kusintha. Cholembedwa chomaliza chinavomerezedwa ndipo chinasindikizidwa mu Ogasiti 2025 mu Chinese Journal of Laboratory Medicine, Volume 48, Nkhani 8.

Kugwirizana kumeneku kumapereka chitsogozo chokhazikika cha kuyang'anira mankhwala ofanana ndi heparin m'ma laboratories, kupereka chithandizo chodalirika kwambiri cha labotale kuti chithandizo chamankhwala choletsa magazi kuundana chigwiritsidwe ntchito bwino komanso motetezeka. Pamapeto pake, izi zithandiza odwala osiyanasiyana ndikupanga chithandizo cha heparin choletsa magazi kuundana chikhale chokhazikika komanso cholondola.

CHIDULE

Mankhwala ofanana ndi a heparin amagwiritsidwa ntchito kwambiri poletsa magazi kuundana popewa ndi kuchiza matenda a thromboembolic. Kugwiritsa ntchito bwino komanso kuyang'anira bwino mankhwalawa ndikofunikira kwambiri kuti chithandizo chikhale chotetezeka komanso chogwira mtima. Mgwirizano wa akatswiriwa umachokera ku mabuku ofunikira akudziko ndi apadziko lonse lapansi, poganizira momwe heparin ilili panopa komanso momwe ikuyendera. Idasonkhanitsa gulu la akatswiri m'munda wa antithrombotic, kuphatikizapo akatswiri a labotale ndi azachipatala, kuti akambirane za zizindikiro, mlingo, ndi kuyang'anira heparin. Makamaka, idafotokoza momwe zizindikiro za labotale zimagwiritsidwira ntchito kuchipatala monga anti-Xa activity ndipo idapanga malangizo a akatswiri ndi cholinga cholimbikitsa kugwiritsa ntchito heparin mosamala komanso moyenera komanso kuwongolera kuwunika kwa labotale.Nkhaniyi yasindikizidwanso kuchokera ku: Thrombosis and Hemostasis (CSTH).

Beijing Succeeder Technology Inc. (khodi ya stock: 688338) yakhala ikugwira ntchito yozama kwambiri pa matenda a magazi kuyambira pomwe idakhazikitsidwa mu 2003, ndipo yadzipereka kukhala mtsogoleri pankhaniyi. Likulu lake ku Beijing, kampaniyo ili ndi gulu lamphamvu la kafukufuku ndi chitukuko, kupanga ndi kugulitsa, lomwe likuyang'ana kwambiri pakupanga ndi kugwiritsa ntchito ukadaulo wozindikira matenda a magazi ndi magazi.

Ndi luso lake lapamwamba kwambiri, Succeeder yapambana ma patent ovomerezeka 45, kuphatikiza ma patent opanga zinthu 14, ma patent a utility model 16 ndi ma patent opanga mapangidwe 15. Kampaniyo ilinso ndi ma satifiketi 32 olembetsera zida zamankhwala a Class II, ma satifiketi atatu olembera mafayilo a Class I, ndi satifiketi ya EU CE ya zinthu 14, ndipo yapambana satifiketi ya ISO 13485 yoyang'anira khalidwe kuti iwonetsetse kuti khalidwe la malonda ndi labwino komanso lokhazikika.

Succeeder si kampani yofunika kwambiri ya Beijing Biomedicine Industry Leapfrog Development Project (G20) yokha, komanso idalowa bwino mu Science and Technology Innovation Board mu 2020, zomwe zidapangitsa kuti kampaniyo ikule bwino kwambiri. Pakadali pano, kampaniyo yamanga netiweki yogulitsa mdziko lonse yomwe imakhudza othandizira ndi maofesi ambirimbiri. Zogulitsa zake zimagulitsidwa bwino m'madera ambiri mdzikolo. Ikukulitsanso misika yakunja ndikupitilizabe kupititsa patsogolo mpikisano wake wapadziko lonse lapansi.